Product
Combination of ASWD and DOXIL
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
Combination Therapy With Liposomal Doxorubicin and Withaferin A (Ashwagandha, ASWD) in Recurrent Ovarian CancerStatus: Recruiting, Estimated PCD: 2026-11-01